Editorial: Community series in recent advances in potential biomarkers for rheumatic diseases and in cell-based therapies in the management of inflammatory rheumatic diseases, volume II

Saved in:
Bibliographic Details
Main Authors: Katarzyna Bogunia-Kubik, Philippe Saas, Eric Toussirot
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2024.1530739/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841560985188433920
author Katarzyna Bogunia-Kubik
Philippe Saas
Philippe Saas
Eric Toussirot
author_facet Katarzyna Bogunia-Kubik
Philippe Saas
Philippe Saas
Eric Toussirot
author_sort Katarzyna Bogunia-Kubik
collection DOAJ
format Article
id doaj-art-ab2c1a5a37574d1f87aed6fc4c7e98b2
institution Kabale University
issn 1664-3224
language English
publishDate 2025-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj-art-ab2c1a5a37574d1f87aed6fc4c7e98b22025-01-03T08:55:00ZengFrontiers Media S.A.Frontiers in Immunology1664-32242025-01-011510.3389/fimmu.2024.15307391530739Editorial: Community series in recent advances in potential biomarkers for rheumatic diseases and in cell-based therapies in the management of inflammatory rheumatic diseases, volume IIKatarzyna Bogunia-Kubik0Philippe Saas1Philippe Saas2Eric Toussirot3Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wroclaw, PolandInstitute for Advanced Biosciences, Team: Epigenetics, Immunity, Metabolism, Cell Signaling & Cancer, Inserm U 1209, CNRS UMR 5309, Université Grenoble Alpes, Grenoble, FranceEtablissement Français du Sang Auvergne-Rhône-Alpes, R&D Laboratory, Grenoble, FranceUniversité de Franche Comté, INSERM Centre Investigation Clinique CIC-1431, CHU de Besançon, Besançon, Francehttps://www.frontiersin.org/articles/10.3389/fimmu.2024.1530739/fullTNF inhibitorsbiomarkerscell-based therapyinflammatory rheumatic diseasespsoriatic arthritisrheumatoid arthritis
spellingShingle Katarzyna Bogunia-Kubik
Philippe Saas
Philippe Saas
Eric Toussirot
Editorial: Community series in recent advances in potential biomarkers for rheumatic diseases and in cell-based therapies in the management of inflammatory rheumatic diseases, volume II
Frontiers in Immunology
TNF inhibitors
biomarkers
cell-based therapy
inflammatory rheumatic diseases
psoriatic arthritis
rheumatoid arthritis
title Editorial: Community series in recent advances in potential biomarkers for rheumatic diseases and in cell-based therapies in the management of inflammatory rheumatic diseases, volume II
title_full Editorial: Community series in recent advances in potential biomarkers for rheumatic diseases and in cell-based therapies in the management of inflammatory rheumatic diseases, volume II
title_fullStr Editorial: Community series in recent advances in potential biomarkers for rheumatic diseases and in cell-based therapies in the management of inflammatory rheumatic diseases, volume II
title_full_unstemmed Editorial: Community series in recent advances in potential biomarkers for rheumatic diseases and in cell-based therapies in the management of inflammatory rheumatic diseases, volume II
title_short Editorial: Community series in recent advances in potential biomarkers for rheumatic diseases and in cell-based therapies in the management of inflammatory rheumatic diseases, volume II
title_sort editorial community series in recent advances in potential biomarkers for rheumatic diseases and in cell based therapies in the management of inflammatory rheumatic diseases volume ii
topic TNF inhibitors
biomarkers
cell-based therapy
inflammatory rheumatic diseases
psoriatic arthritis
rheumatoid arthritis
url https://www.frontiersin.org/articles/10.3389/fimmu.2024.1530739/full
work_keys_str_mv AT katarzynaboguniakubik editorialcommunityseriesinrecentadvancesinpotentialbiomarkersforrheumaticdiseasesandincellbasedtherapiesinthemanagementofinflammatoryrheumaticdiseasesvolumeii
AT philippesaas editorialcommunityseriesinrecentadvancesinpotentialbiomarkersforrheumaticdiseasesandincellbasedtherapiesinthemanagementofinflammatoryrheumaticdiseasesvolumeii
AT philippesaas editorialcommunityseriesinrecentadvancesinpotentialbiomarkersforrheumaticdiseasesandincellbasedtherapiesinthemanagementofinflammatoryrheumaticdiseasesvolumeii
AT erictoussirot editorialcommunityseriesinrecentadvancesinpotentialbiomarkersforrheumaticdiseasesandincellbasedtherapiesinthemanagementofinflammatoryrheumaticdiseasesvolumeii